$0.952
+0.002 (+0.23%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Veraxa Biotech AG (VRXA) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting VRXA is Strong sell.
Veraxa Biotech AG (VRXA) 20-Day simple moving average is 1.06, while Veraxa Biotech AG (VRXA) share price is $—, making it Sell.
Veraxa Biotech AG (VRXA) 60-Day simple moving average is 1.36, while Veraxa Biotech AG (VRXA) share price is $—, making it Sell.
Technical Analysis for VRXA
AI Technical VRXAAs of 2026-11-02, the technical board for Veraxa Biotech AG (VRXA) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $0.95 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 37.146, MACD stands at -0.0916 (Sell), Stochastic %K stands at 4.689 (Buy), Stochastic %D stands at 15.73 and CCI stands at -87.636.
VRXA trades below the 60-day SMA (1.36) and below the 200-day SMA (2.54). Immediate resistance sits at Classic R1 1.19, then R2 1.37. Support sits at Classic S1 0.89, then S2 0.77.
Veraxa Biotech AG (VRXA) Support & Resistance Level
Veraxa Biotech AG (VRXA) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 37.146 |
| STOCHk_14_3_3 | 4.689 |
| STOCHd_14_3_3 | 15.730 |
| CCI_20 | -87.636 |
| AO_5_34 | -0.118 |
| MOM_10 | -0.078 |
| MACD_12_26_9 | -0.092 |
Veraxa Biotech AG (VRXA) Relative Strength Index (RSI_14) is 37.146, creating a Neutral signal.
Veraxa Biotech AG (VRXA) Stochastic %K is 4.689, creating a Buy signal.
Veraxa Biotech AG (VRXA) Stochastic %D is 15.730, creating a Buy signal.
Veraxa Biotech AG (VRXA) CCI_20 is -87.636, creating a Neutral signal.
Veraxa Biotech AG (VRXA) Awesome Oscillator (AO) is -0.118, creating a Sell signal.
Veraxa Biotech AG (VRXA) Momentum (MOM) is -0.078, creating a Sell signal.
Veraxa Biotech AG (VRXA) Moving Average Convergence Divergence (MACD) is -0.092, creating a Sell signal.
Veraxa Biotech AG (VRXA) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.012 | Sell |
| MA_10 | 1.015 | Sell |
| MA_20 | 1.059 | Sell |
| MA_60 | 1.359 | Sell |
| MA_200 | 2.539 | Sell |
| MA_250 | 2.539 | Sell |
Veraxa Biotech AG (VRXA) 5-Day simple moving average is 1.012, while Veraxa Biotech AG (VRXA) share price is $, making it a Sell.
Veraxa Biotech AG (VRXA) 10-Day simple moving average is 1.015, while Veraxa Biotech AG (VRXA) share price is $, making it a Sell.
Veraxa Biotech AG (VRXA) 20-Day simple moving average is 1.059, while Veraxa Biotech AG (VRXA) share price is $, making it a Sell.
Veraxa Biotech AG (VRXA) 60-Day simple moving average is 1.359, while Veraxa Biotech AG (VRXA) share price is $, making it a Sell.
Veraxa Biotech AG (VRXA) 200-Day simple moving average is 2.539, while Veraxa Biotech AG (VRXA) share price is $, making it a Sell.
Veraxa Biotech AG (VRXA) 250-Day simple moving average is 2.539, while Veraxa Biotech AG (VRXA) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.